CP
Catalyst Pharmaceuticals
CPRX13F as of Jun 30, 2026 · next update ~Nov 14
Limited coverage
Only 1 fund we track owns this stock, so quarterly sentiment and aggregates may be sparse.
Who's buying CPRX
Top funds mostly trimmed Catalyst Pharmaceuticals in Q2 (Apr–Jun)
Buying:
FundsInsidersCongress
- Top funds0 of 1 bought more, 1 sold some. Largest: Third Avenue Management, $6.6M (1% of its portfolio).
- InsidersNo buys, 3 sales in 12 months.
- CongressNo trades disclosed in the last 12 months.
1 fund$6.6M held1.1% avg. weightQ2: 0 bought / 1 sold
13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).
Share price · market data, not from 13F reports
Q2 2026
Insider trades (Form 4)
Last 2 years · 23 filings